Dicerna Pharmaceuticals

- NASDAQ:DRNA
Last Updated 2021-07-30
  • Dicerna Pharmaceuticals is focused on the discovery and development of innovative treatments for rare inherited diseases.
  • Locations

    • Watertown MA
  • Total Funding (USD)

    395.5 million
  • Security

    Type: ORD
    CUSIP: 253031108
    ISIN: US2530311081
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.